Table 3. In-hospital cardiac events.
| Homocysteine level | < 12.0 µmol/L | ≥ 12.0 µmol/L | P value |
|---|---|---|---|
| Number of patients | 883 | 424 | |
| Death, n (%) | 6 (0.7) | 12 (2.9) | 0.004 |
| Cardiac | 6 (0.7) | 10 (2.4) | 0.014 |
| Non-Cardiac | 0 (0) | 2 (0.5) | 0.105 |
| Non-fatal MI, n (%) | 0.607 | ||
| NSTEMI | 18 (2.0) | 8 (1.9) | 1.00 |
| STEMI | 2 (0.2) | 0 | 1.00 |
| Acute stent thrombosis, n (%) | 3 (0.3) | 2 (0.5) | 0.662 |
| Subacute stent thrombosis, n (%) | 5 (0.6) | 4 (0.9) | 0.483 |
| Emergent bypass surgery, n (%) | 2 (0.2) | 1 (0.2) | 1.000 |
| Non-fatal stroke, n (%) | 2 (0.2) | 0 | 1.00 |
| MACE, n (%) | 33 (3.7) | 19 (4.5) | 0.546 |
MACE: major adverse cardiac event; MI: myocardial infarction; NSTEMI: non ST-segment elevation myocardial infarction; STEMI: ST- segment elevation myocardial infarction